NEWS
Cochlear hits record high ahead of results announcement
MELBOURNE: Shares in hearing-aid company Cochlear hit an all-time high of $257.76 around lunchtime today,… read more
Telix hopeful for product approvals today posts $33m loss
MELBOURNE: Drug developer Telix is banking on its flagship prostate cancer imaging product being approved… read more
18 new senior healthcare executives sought for key roles
MELBOURNE: Eighteen senior healthcare, aged and retirement village executive positions remain open. New positions listed… read more
Cochlear boosts final dividend to $1.40 as sales surge
MELBOURNE: Cochlear investors will see full-year dividends jump close to 60 per cent on last… read more
